Yan Wang

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0001-8750-9341

发表论文 40 篇 · 总被引 163 次 · h-index 6

代表论文

• Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 32)
• 357P: Association of TROP2 quantitative continuous scoring (QCS) normalised membrane ratio (NMR) with efficacy in Chinese patients (pts) with advanced/metastatic non-small cell lung cancer (a/mNSCLC) treated with datopotamab deruxtecan (Dato-DXd) in TROPION-PanTumor02 (2025 · Journal of Thoracic Oncology · 被引 7)
• HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer (2023 · Translational Cancer Research · 被引 6)
• Pan-cancer analysis identifies adhesion G protein-coupled receptor G6 as a potential prognostic and immunotherapeutic biomarker with its functional validation (2025 · International Journal of Biological Macromolecules · 被引 5)
• Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study (2025 · Clinical Cancer Research · 被引 5)
• Shifting landscapes of gender equity in oncology journals: a decade of authorship trends (2025 · Molecular Cancer · 被引 5)